```html

Quinine Intoxication

Overview

Quinine intoxication (also called quinine toxicity or quinine poisoning) occurs when the level of quinine in the bloodstream becomes high enough to cause adverse systemic effects. Quinine is an alkaloid derived from the bark of the South American cinchona tree. Historically it was used as the first effective treatment for malaria, and today it is still prescribed in low doses for nocturnal leg cramps, certain arrhythmias, and as part of combination therapy for severe malaria.

Because quinine has a narrow therapeutic index—meaning the difference between a therapeutic dose and a toxic dose is small—over‑dosage, drug interactions, or impaired metabolism can quickly lead to intoxication.

• Population affected: Adults are most commonly affected, especially those who self‑medicate with over‑the‑counter “tonic water” (which contains up to 83 mg quinine per liter in the United States) or who receive quinine prescriptions for malaria or leg cramps.
• Prevalence: True cases of severe quinine poisoning are rare in the United States (< 0.2 cases per 100,000 people annually) but are more common in regions where quinine is used extensively for malaria treatment, such as sub‑Saharan Africa and parts of South‑Asia. In the U.S., the FDA estimates < 100 emergency department visits per year are directly linked to quinine‑containing products.<sup>[1] CDC, 2022</sup>

Symptoms

Symptoms can appear within minutes to several hours after ingestion, depending on the dose and individual metabolism. They range from mild (e.g., tinnitus) to life‑threatening (e.g., cardiac arrhythmias). The most common manifestations include:

Gastrointestinal

• Nausea and vomiting: Often the first sign, may be severe and persistent.
• Abdominal cramping: Can mimic other causes of acute abdomen.
• Diarrhea: Occasionally bloody in very high exposures.

Neurologic

• Tinnitus (ringing in the ears): Highly characteristic of quinine toxicity.
• Hearing loss or vertigo: May be transient or, in rare cases, permanent.
• Headache, dizziness, or light‑headedness.
• Peripheral neuropathy: Tingling, numbness, or a “pins‑and‑needles” sensation, especially in the hands and feet.
• Seizures: Typically occur at higher plasma concentrations (> 10 µg/mL).

Cardiovascular

• Hypotension: Due to vasodilation and direct myocardial depression.
• Bradycardia or tachycardia.
• Arrhythmias: Including ventricular tachycardia, atrial fibrillation, and QT‑interval prolongation that can precipitate torsades de pointes.

Hematologic

• Thrombocytopenia: Sudden drop in platelets, sometimes with petechiae.
• Hemolytic anemia: Particularly in patients with glucose‑6‑phosphate dehydrogenase (G6PD) deficiency.

Renal

• Acute kidney injury (AKI): Resulting from direct tubular toxicity and hemoglobinuria.

Other

• Flu‑like symptoms: Fever, chills, malaise.
• Skin reactions: Rash, pruritus, or Stevens‑Johnson‑like eruptions (rare).

Causes and Risk Factors

Quinine intoxication results from exposure to a dose that exceeds the body’s capacity to metabolize and excrete the drug.

Primary Causes

• Acute overdose: Intentional or accidental ingestion of large amounts (e.g., taking multiple quinine tablets or drinking excessive tonic water).
• Drug interactions: Medications that inhibit hepatic CYP3A4 (e.g., macrolide antibiotics, certain antifungals) raise quinine levels.
• Renal or hepatic impairment: Reduces clearance, leading to accumulation.
• Chronic high‑dose therapy: Long‑term use for leg cramps without medical supervision.

Risk Factors

• Age > 65 years (decreased renal function).
• Pre‑existing liver disease (cirrhosis, hepatitis).
• G6PD deficiency (higher risk of hemolysis).
• Concurrent use of CYP3A4 inhibitors (e.g., clarithromycin, ketoconazole).
• History of cardiac conduction abnormalities.
• Pregnancy: The FDA classifies quinine as Category C; maternal toxicity can affect the fetus.

Diagnosis

Diagnosis is clinical but must be supported by laboratory and electro‑cardiographic data.

History and Physical Examination

• Document timing, amount, and source of quinine exposure.
• Identify symptoms consistent with toxicity (tinnitus, arrhythmias, etc.).
• Check for signs of dehydration, hypotension, or rash.

Laboratory Tests

• Serum quinine level: Measured by high‑performance liquid chromatography (HPLC). Toxicity usually > 5 µg/mL; severe toxicity > 10 µg/mL.<sup>[2] Mayo Clinic, 2023</sup>
• Complete blood count (CBC) – look for thrombocytopenia or hemolytic anemia.
• Basic metabolic panel – assess electrolytes, renal function (creatinine, BUN).
• Liver function tests – ALT, AST, bilirubin.
• Coagulation profile – PT/INR if bleeding is suspected.

Cardiac Evaluation

• 12‑lead ECG – QTc prolongation (> 450 ms in men, > 470 ms in women) is a red flag.
• Continuous cardiac monitoring for patients with arrhythmias.

Other Studies (when indicated)

• Chest X‑ray – to rule out pulmonary edema if severe hypotension.
• Ultrasound of kidneys – if AKI is suspected.
• G6PD assay – especially in patients of African, Mediterranean, or Asian descent.

Treatment Options

Management focuses on de‑contamination, supportive care, and specific interventions to counteract quinine’s cardiac and hematologic effects.

Immediate Measures

• Gastrointestinal decontamination: Activated charcoal (1 g/kg, max 50 g) administered within 1–2 hours of ingestion; repeat dose may be considered if delayed absorption is suspected.
• Consider gastric lavage only in massive, life‑threatening ingestions and when performed by experienced personnel.

Supportive Care

• IV fluids to maintain blood pressure and renal perfusion.
• Correct electrolyte disturbances (especially potassium and magnesium, which affect QT interval).
• Oxygen supplementation if hypoxic.
• Antiemetics (ondansetron, metoclopramide) for nausea/vomiting.

Cardiac Management

• Continuous cardiac monitoring.
• IV magnesium sulfate (2 g over 15 min) for QT prolongation or torsades de pointes.
• In cases of severe bradycardia or hypotension, atropine 0.5 mg IV push, repeat q3–5 min up to 3 mg.
• Advanced cardiac life support (ACLS) protocols for malignant arrhythmias.

Hematologic Interventions

• Transfusion of platelets or packed red blood cells if severe thrombocytopenia or anemia with hemodynamic compromise.
• Consider IV immunoglobulin (IVIG) for immune‑mediated thrombocytopenia, though evidence is limited.

Renal Support

• Monitor urine output; insert Foley catheter if necessary.
• Hemodialysis is rarely required because quinine is moderately protein‑bound, but it can be used for severe AKI with refractory metabolic acidosis.

Pharmacologic Antidotes

There is no specific antidote for quinine. Therapy therefore relies on the measures above and on removing the offending agent.

Discharge Planning

• Observation for at least 24 hours after symptom resolution, with serial ECGs.
• Patient education on avoiding quinine‑containing products.

Living with Quinine Intoxication

Even after recovery, patients may experience lingering effects. The following strategies help mitigate long‑term impact:

• Medication review: Have a pharmacist or physician assess all prescriptions, over‑the‑counter meds, and supplements for potential interactions.
• Hearing monitoring: Annual audiograms for those who reported tinnitus or hearing loss.
• Cardiac follow‑up: Repeat ECG at 1 month and 6 months to ensure QT interval normalizes.
• Renal function checks: Serum creatinine and eGFR every 3–6 months for the first year.
• Hydration: Aim for ≥ 2 L of water daily (or as advised by a clinician) to aid renal clearance.
• Dietary considerations: Limit caffeine and alcohol, which can exacerbate QT prolongation.
• Psychological support: If overdose was intentional, arrange counseling or mental‑health referral.

Prevention

Because most cases stem from misuse or lack of awareness, prevention is straightforward:

1. Prescription oversight: Only use quinine when prescribed, and at the exact dose advised.
2. Read labels: Over‑the‑counter tonic water contains quinine; limit consumption to ≤ 1 L per day (≈ 83 mg quinine).
3. Avoid self‑medication for leg cramps: FDA has warned against using quinine for this purpose due to safety concerns.
4. Inform healthcare providers of all meds: Especially antibiotics, antifungals, and anti‑arrhythmics.
5. Screen high‑risk patients: Check G6PD status or baseline ECG before initiating quinine therapy.
6. Store medications safely: Keep tablets out of reach of children and away from alcohol.

Complications

If untreated or inadequately managed, quinine intoxication can lead to serious, sometimes irreversible complications:

• Life‑threatening arrhythmias (torsades de pointes, ventricular fibrillation).
• Permanent auditory damage (sensorineural hearing loss).
• Severe hemolysis in G6PD‑deficient individuals, potentially causing acute renal failure.
• Acute kidney injury that may progress to chronic kidney disease.
• Thrombotic microangiopathy leading to multi‑organ dysfunction.
• Fatal outcome: Mortality rates reported in case series range from 5–15 % for severe intoxication, higher in patients with pre‑existing cardiac disease.<sup>[3] WHO, 2021</sup>

When to Seek Emergency Care

---

Sources: [1] Centers for Disease Control and Prevention (CDC). “Emergency Department Visits for Quinine‑Related Adverse Events,” 2022. [2] Mayo Clinic. “Quinine Toxicity: Clinical Presentation & Management,” 2023. [3] World Health Organization (WHO). “Drug Safety and Adverse Reactions: Quinine,” 2021. Additional data from the National Institutes of Health (NIH) and Cleveland Clinic guidelines.

```